NewsBot
06-25-2009, 02:40 AM
HealthDay - WEDNESDAY, June 24 (HealthDay News) -- A new cancer drug called olaparib worked well in an early clinical trial against breast, ovarian and prostate cancers in individuals who were genetically vulnerable to developing these malignancies.
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20090625/hl_hsn/newcancerdrugfightstumorsinthosewithbrcamutations)
(From Yahoo Diseases)
Read the full article... (http://us.rd.yahoo.com/dailynews/rss/diseases/*http://news.yahoo.com/s/hsn/20090625/hl_hsn/newcancerdrugfightstumorsinthosewithbrcamutations)
(From Yahoo Diseases)